Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
New drug-eluting stent concepts.
Wessely R. Wessely R. Nat Rev Cardiol. 2010 Apr;7(4):194-203. doi: 10.1038/nrcardio.2010.14. Epub 2010 Mar 2. Nat Rev Cardiol. 2010. PMID: 20195268 Review.
Clinical outcomes with the STENTYS self-apposing coronary stent in patients presenting with ST-segment elevation myocardial infarction: two-year insights from the APPOSITION III (A Post-Market registry to assess the STENTYS self-exPanding COronary Stent In AcuTe MyocardIal InfarctiON) registry.
Lu H, Grundeken MJ, Vos NS, IJsselmuiden AJJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JGP, Amoroso G, de Winter RJ, Koch KT. Lu H, et al. Among authors: wessely r. EuroIntervention. 2017 Aug 4;13(5):e572-e577. doi: 10.4244/EIJ-D-16-00676. EuroIntervention. 2017. PMID: 28191875 Free article. Clinical Trial.
One-year clinical outcomes of the STENTYS Self-Apposing¨ coronary stent in patients presenting with ST-segment elevation myocardial infarction: results from the APPOSITION III registry.
Koch KT, Grundeken MJ, Vos NS, IJsselmuiden AJ, van Geuns RJ, Wessely R, Dengler T, La Manna A, Silvain J, Montalescot G, Spaargaren R, Tijssen JG, Amoroso G. Koch KT, et al. Among authors: wessely r. EuroIntervention. 2015 Jul;11(3):264-71. doi: 10.4244/EIJY15M02_08. EuroIntervention. 2015. PMID: 25692610 Free article. Clinical Trial.
Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating.
Hausleiter J, Kastrati A, Wessely R, Dibra A, Mehilli J, Schratzenstaller T, Graf I, Renke-Gluszko M, Behnisch B, Dirschinger J, Wintermantel E, Schömig A; investigators of the individualizable durg-eluting Stent System to Abrogate Restenosis Project. Hausleiter J, et al. Among authors: wessely r. Eur Heart J. 2005 Aug;26(15):1475-81. doi: 10.1093/eurheartj/ehi405. Epub 2005 Jun 23. Eur Heart J. 2005. PMID: 15975990 Clinical Trial.
Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis.
Mehilli J, Byrne RA, Wieczorek A, Iijima R, Schulz S, Bruskina O, Pache J, Wessely R, Schömig A, Kastrati A; Intracoronary Stenting and Angiographic Restenosis Investigators--Test Efficacy of Rapamycin-eluting Stents with Different Polymer Coating Strategies (ISAR-TEST-3). Mehilli J, et al. Among authors: wessely r. Eur Heart J. 2008 Aug;29(16):1975-82. doi: 10.1093/eurheartj/ehn253. Epub 2008 Jun 11. Eur Heart J. 2008. PMID: 18550554 Clinical Trial.
60 results